Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for System Suitability Evaluation – V 2.0

Posted on By

Analytical Method Development: SOP for System Suitability Evaluation – V 2.0

Standard Operating Procedure for System Suitability Evaluation in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/353/2025
Supersedes SOP/AMD/353/2022
Page No. Page 1 of 11
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

This SOP defines the standard procedure for evaluating system suitability parameters before initiating sample analysis during analytical method development and validation. System suitability ensures the integrity of the chromatographic system and accuracy of analytical results.

2. Scope

This procedure is

applicable to all chromatographic (HPLC, GC, UPLC) and instrumental analytical methods used in the Analytical Method Development (AMD) department.

3. Responsibilities

  • Analyst: Performs and documents system suitability evaluations prior to sample injection.
  • AMD Documentation Officer: Maintains and verifies logs and result sheets for each system suitability test.
  • QA Reviewer: Reviews compliance with pre-defined criteria and initiates deviation reports if necessary.
See also  Analytical Method Development: Total Viable Count Method Optimization - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that system suitability evaluations are conducted, recorded, and reviewed for every analytical run.

5. Procedure

5.1 General Guidelines

  1. Perform system suitability prior to each sample sequence or analytical batch.
  2. Use a freshly prepared system suitability solution or standard solution.
  3. Ensure that all system settings (temperature, flow rate, injection volume) are in accordance with method parameters.

5.2 System Suitability Parameters

Typical parameters include but are not limited to:

  • Retention Time (RT)
  • Resolution (Rs)
  • Theoretical Plates (N)
  • Tailing Factor (T)
  • Repeatability (%RSD for peak area or height)

5.3 Acceptance Criteria

  1. Refer to the validated method or protocol for specific parameter thresholds.
  2. For example:
    • Resolution between critical pair: ≥ 2.0
    • Tailing Factor: ≤ 2.0
    • Repeatability: %RSD ≤ 2.0 for replicate injections
    • Theoretical Plates: As per method validation report
See also  Analytical Method Development: Limit Test for Chloride/Sulphate Development - V 2.0

5.4 Execution Steps

  1. Prepare system suitability solution as per method.
  2. Inject 5–6 replicates and record results.
  3. Use instrument software to calculate suitability metrics.
  4. Document all readings in System Suitability Log (Annexure-1).

5.5 Actions on Failure

  1. If parameters do not meet acceptance criteria:
    • Stop sample injections.
    • Check mobile phase preparation, column condition, detector baseline.
    • Perform necessary corrective actions (e.g., column flushing, flow rate adjustment).
    • Repeat system suitability check after adjustments.

5.6 Documentation

  1. Record all suitability results in Annexure-1.
  2. Attach printouts or screenshots from instrument software.
  3. Deviations must be logged using Deviation Report Format (Annexure-2).

6. Abbreviations

  • RT: Retention Time
  • Rs: Resolution
  • N: Theoretical Plates
  • RSD: Relative Standard Deviation

7. Documents

  1. Annexure-1: System Suitability Evaluation Log
  2. Annexure-2: Deviation Report Format

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <621> – Chromatography
  • FDA Guidance on Chromatographic Data Integrity

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ravi Sharma Sapna Desai Dr. Ishaan Mehta
Designation AMD Analyst QA Reviewer Head – Analytical Method Development
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: System Suitability Evaluation Log

Date Instrument ID Method RT Rs Tailing %RSD Status
01/06/2025 HPLC-102 ASSAY-001 5.6 2.3 1.2 1.1 Pass

Annexure-2: Deviation Report Format

Deviation ID Date Description Root Cause Corrective Action Status
DEV-353-01 01/06/2025 High tailing factor Column aging Column replacement Closed

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Included enhanced evaluation parameters and deviation handling Annual SOP Review Dr. Ishaan Mehta
01/06/2022 1.0 Initial release New SOP QA Head
See also  Analytical Method Development: Oxidation-Reduction Titration Development - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Review of Analytical Data – V 2.0
Next Post: Analytical Method Development: SOP for Selection of Chromatographic Conditions – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version